Similar to EGFR, PDGFR promotes the proliferation and migration of PASMCs during PAH development by activating Nox4-induced abnormal oxidative stress, which can be effectively eliminated by CD248 knockout or antibody therapy [57]. The gene discussed is NOX4; the disease is pulmonary arterial hypertension.